Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Clin Cancer Res. 2016 May 25;22(19):4776–4785. doi: 10.1158/1078-0432.CCR-16-0506

Table 2.

Most Common Adverse Events Occurring in >20% Patients (regardless of causality)

Grade, No.
Symptom* 1 2 3 4 Total No. (% pts)
Nausea 21 6 0 0 27 (60%)
Injection Site Reaction 24 2 0 0 26 (58%)
Fatigue 16 5 4 0 25 (56%)
Headache 20 2 0 0 22 (49%)
Vomiting 16 4 1 0 21 (47%)
Alopecia 8 8 0 0 16 (36%)
Dizziness 11 3 0 0 14 (31%)
Seizure 4 4 3 2 13 (29%)
Cough 9 2 0 0 11 (24%)

Abbreviations: pts, patients.

*

Patients may have experienced multiple AEs of the same type.